These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31389037)
1. Evaluation of the pattern and kinetics of degradation of adalimumab using a stability-indicating orthogonal testing protocol. Hassan LA; Al-Ghobashy MA; Abbas SS Biomed Chromatogr; 2019 Dec; 33(12):e4676. PubMed ID: 31389037 [TBL] [Abstract][Full Text] [Related]
2. Comparative Assessment of the Effect of Hyper-glycosylation on the Pattern and Kinetics of Degradation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol. Moenes EM; Al-Ghobashy MA; Mohamed AA; Salem MY J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():405-414. PubMed ID: 29157782 [TBL] [Abstract][Full Text] [Related]
3. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol. Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046 [TBL] [Abstract][Full Text] [Related]
4. Analytical comparability study of anti-CD20 monoclonal antibodies rituximab and obinutuzumab using a stability-indicating orthogonal testing protocol: Effect of structural optimization and glycoengineering. Trabik YA; Moenes EM; Al-Ghobashy MA; Nebsen M; Ayad MF J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1159():122359. PubMed ID: 32920338 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive stability assessment of insulin degludec using New customized validated RP-HPLC and SEC-HPLC methods in an orthogonal testing protocol. Abdelwaly EA; Mohamed AA; El-Kosasy AM; Ayad MF J Pharm Biomed Anal; 2021 Sep; 203():114175. PubMed ID: 34098506 [TBL] [Abstract][Full Text] [Related]
7. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals. Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190 [TBL] [Abstract][Full Text] [Related]
8. Degradation kinetics study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a validated stability-indicating RP-HPLC method. Kim KS; Yang ES; Kim DS; Kim DW; Yong CS; Kim JO; Jin SG; Choi HG J Pharm Biomed Anal; 2018 Feb; 149():374-380. PubMed ID: 29145099 [TBL] [Abstract][Full Text] [Related]
10. Stability assessment of Polatuzumab vedotin and Brentuximab vedotin using different analytical techniques. Mohamed HE; Al-Ghobashy MA; Abbas SS; Boltia SA J Pharm Biomed Anal; 2023 May; 228():115249. PubMed ID: 36827859 [TBL] [Abstract][Full Text] [Related]
11. Stability of new potential ACE inhibitor in the aqueous solutions of different pH. Roskar R; Simoncic Z; Gartner A; Kmetec V J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody. Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394 [TBL] [Abstract][Full Text] [Related]
13. RP-HPLC stability-indicating assay method for talinolol and characterization of its degradation products. Sinha VR; Ghai D J Chromatogr Sci; 2011; 49(10):786-95. PubMed ID: 22080807 [TBL] [Abstract][Full Text] [Related]
14. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS. Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215 [TBL] [Abstract][Full Text] [Related]
15. A validated stability indicating LC method for oxcarbazepine. Pathare DB; Jadhav AS; Shingare MS J Pharm Biomed Anal; 2007 Apr; 43(5):1825-30. PubMed ID: 17223301 [TBL] [Abstract][Full Text] [Related]
16. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis. Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016 [TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic and spectrofluorimetric assays of empagliflozin: Applied to degradation kinetic study and content uniformity testing. Abdel-Ghany MF; Ayad MF; Tadros MM Luminescence; 2018 Aug; 33(5):919-932. PubMed ID: 29737023 [TBL] [Abstract][Full Text] [Related]
19. Determination of nimodipine in the presence of its degradation products and overall kinetics through a stability-indicating LC method. Riekes MK; Rauber GS; Kuminek G; Tagliari MP; Cardoso SG; Stulzer HK J Chromatogr Sci; 2013 Jul; 51(6):511-6. PubMed ID: 23118209 [TBL] [Abstract][Full Text] [Related]
20. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products. Hadad GM J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]